July 6 (SeeNews) - Serbia's Bankruptcy Supervision Agency is inviting bids for the purchase of assets of insolvent pharmaceutical company Jugoremedija, the agency said.
The estimated value of the assets of Jugoremedija for sale stands 3.887 billion dinars ($38.6 million/32.9 million euro), the Bankruptcy Supervision Agency said in a notice earlier this week.
You can subscribe to our M&A newsletter here
According to Serbian media reports, a Russian company is interested in the acquisition of the assets of Jugoremedija.
The deadline for the submission of bids is August 6.
Jugoremedija was declared bankrupt in November 2016, after which the Zrenjanin Commercial Court ordered the sale of its assets to repay creditors. However, Jugoremedija’s biggest creditor Heta Real Estate Serbia, a subsidiary of Austria's Heta Asset Resolution, failed to deliver a viable restructuring plan for the drug maker within the deadline, the Zrenjanin Commercial Court said.
An auction for the assets of Jugoremendija was carried out in February, but it did not attract any bid. According to media reports, a Swiss company was interested in Jugoremedija back then.
(1 euro = 117.992 dinar)